Max Rubinstein

Max Rubinstein

Associate Statistician

Max Rubinstein is an associate statistician at RAND. His methodological interests include study design (experimental and observational), causal mediation analysis, doubly robust estimation, partial identification, methods for state-level policy analysis, and missing data. He has used these methods to study a variety of policy and public health challenges, including the opioid crisis, reducing costs and improving quality of care for Medicare populations, clinical quality measurement, and better serving adults with serious mental illness. He received his Ph.D. in statistics and public policy from Carnegie Mellon University. 

Education

Ph.D. in statistics and public policy, Carnegie Mellon University; A.B. in history, University of Chicago

Selected Work

  • Joseph Antonelli, Max Rubinstein, Denis Agniel, Rosanna Smart, Elizabeth Stuart, Matthew Cefalu, Terry Schell, Joshua Eagan, Elizabeth Stone, Max Griswold, Beth Ann Griffin, "Autoregressive models for panel data causal inference with application to state-level opioid policies," Annals of Applied Statistics, 2026 (forthcoming)
  • Max Rubinstein, Maria Cuellar, Daniel Malinsky, "Mediated probabilities of causation," Journal of Causal Inference, 2025
  • Max Rubinstein, Amelia Haviland, David Choi, "Balancing weights for region-level analysis: the effect of medicaid expansion on the uninsurance rate among states that did not expand medicaid," Annals of Applied Statistics, 2023
  • Max Rubinstein, Zach Branson, Edward H Kennedy, "Heterogeneous interventional effects with multiple mediators: Semiparametric and nonparametric approaches," Journal of Causal Inference, 2023
  • Max Rubinstein, Denis Agniel, Larry Han, Marcela Horvitz-Lennon, Sharon-Lise Normand, "Bounding causal effects with an unknown mixture of informative and non-informative missingness," Journal of Causal Inference, 2026 (forthcoming)

Authored by Max Rubinstein

  • Content Type
  • Topic
  • Region
  • Date
5 Results